Kymera Therapeutics KYMR Increase Decrease In Operating Lease Liabilities
Increase Decrease In Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept kymr:IncreaseDecreaseInOperatingLeaseLiabilities.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's increase decrease in operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's increase decrease in operating lease liabilities?
- Kymera Therapeutics (KYMR) reported increase decrease in operating lease liabilities of -$1.36M in Q1 2026.
- How has Kymera Therapeutics's increase decrease in operating lease liabilities changed year-over-year?
- Kymera Therapeutics's increase decrease in operating lease liabilities decreased by 17.7% year-over-year, from -$1.15M to -$1.36M.
- What is the long-term trend for Kymera Therapeutics's increase decrease in operating lease liabilities?
- Over 3 years (2021 to 2025), Kymera Therapeutics's increase decrease in operating lease liabilities has grown at a 70.6% compound annual growth rate (CAGR), from -$1.02M to -$5.04M.
- What does increase decrease in operating lease liabilities mean?
- Represents the net change in the present value of future lease payments for operating leases. This metric reflects the reduction of lease obligations through cash payments and adjustments for new or modified lease agreements.